SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTOB.L Regulatory News (STOB)

  • There is currently no data for STOB

Directorate Changes

21 May 2014 07:00

RNS Number : 6592H
Stobart Group Limited
21 May 2014
 

STOBART GROUP LIMITED

('Stobart' or 'the Group')

 

Directorate Changes

 

Stobart is pleased to announce the appointment of John Garbutt and John Coombs to its Board as non-executive directors and Richard Butcher as an executive director with effect from 1 July 2014. Paul Orchard-Lisle and Michael Kayser will be leaving the Board at the Group's AGM on 26 June 2014 after many years of valuable service to the Group.

 

Richard Butcher joined the Group in February 1997 and leads its Estates and Energy businesses. He will join the Board as an executive director with responsibility for the Group's Infrastructure, Energy and Rail Divisions. He also serves as Company Secretary and will be succeeded in that role, on his appointment to the Board, by Kate Willard who is deputy Company Secretary at present.

 

John Garbutt obtained a BSc Econ Honours degree from the LSE and began his career with Rowe & Pitman. He subsequently worked at ICI, Touche Remnant and Schroders and became a Director at Kleinwort Benson in 1987. Between 1991 and 2013 he worked at HSBC in a variety of senior roles, most recently as Director, Global Head of Corporate Governance in the investment businesses. John is a Justice of the Peace and an Alderman in the City of London and has had a wide range of charitable and civic appointments.

 

John Coombs is a Managing Director at Unilever Ventures where he has chaired the investment committee for the past 12 years. He has served as a non-executive director or non-executive chairman on the boards of 12 investee companies. John helped establish Unilever's ventures business in 2001, having joined Unilever in 1981 following his graduation in Engineering Science from Oxford University, and went on to hold a wide range of senior positions.

 

Paul Orchard-Lisle joined the Board in May 2011. He has chaired the Group's Property Board since joining the Group and we are pleased that he will continue in that role. Michael Kayser joined the Board in March 2008 and chairs the Audit Committee. The Board is grateful for the significant contributions that Paul and Michael have made to the Group.

 

Iain Ferguson commented: "I would like to thank Paul Orchard-Lisle and Michael Kayser, on the Group's behalf, for their service to the Board. I wish them well in the future and look forward to continuing to benefit from Paul's Chairmanship of our Property Board.

 

We welcome John Coombs and John Garbutt to the Group and look forward to working with Richard in his new role. Between them they bring significant commercial, financial and regulatory experience to the Board." 

No further information is required to be disclosed pursuant to Listing Rule 9.6.13.

 

 

ENQUIRIES

 

Stobart

+44 020 7851 9090

Andrew Tinkler, Chief Executive Officer

Ben Whawell, Chief Financial Officer

 

Lansons

Tony Langham (tonyl@lansons.com)

+44 20 7294 3617 / +44 7979 692287

Anna Schirmer (annas@lansons.com)

+44 20 7294 3605

 

Influence Associates

 

+44 20 7287 9610

Stuart Dyble/James Andrew

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGUGDUSUDBGSB
Date   Source Headline
6th Jul 20187:00 amRNSAGM Statement
2nd Jul 201812:46 pmRNSAGM Update
28th Jun 20184:50 pmRNSCorrection: Director/PDMR Shareholding
27th Jun 20186:24 pmRNSDirector/PDMR Shareholding
27th Jun 20185:51 pmRNSTR-1: Notification of Major Interest in Shares
27th Jun 20185:48 pmRNSTR-1: Notification of Major Interest in Shares
26th Jun 201810:39 amRNSCorrection: Transfer of Shares
26th Jun 20187:00 amRNSTransfer of Shares
25th Jun 20187:00 amRNSRequisitioned EGM - Posting of Circular
25th Jun 20187:00 amRNSCorrection: Transfer of Shares
22nd Jun 20187:00 amRNSDirector/PDMR Shareholding
20th Jun 20187:00 amRNSTransfer of shares and Total Voting Rights
15th Jun 20187:00 amRNSShareholder letter
14th Jun 20182:07 pmRNSBoard Change
13th Jun 201811:00 amRNSLondon Southend Airport agreement with Ryanair
8th Jun 20187:00 amRNSAGM Notice
7th Jun 201812:36 pmRNSAppointment of Joint Corporate Broker
5th Jun 20187:00 amRNSShareholder requisition
1st Jun 20183:42 pmRNSDate of Annual General Meeting
29th May 20182:41 pmRNSUpdate on AGM and possible Board changes
25th May 20184:51 pmRNSAnnual General Meeting and possible Board changes
10th May 20187:00 amRNSFinal Results
29th Mar 20187:00 amRNSTotal Voting Rights
22nd Mar 20187:18 amRNSStatement Regarding Withdrawal of Stobart Group
22nd Mar 20187:00 amRNSNo Intention to Bid Statement
21st Mar 20182:23 pmRNSForm 8.3 - Flybe Group PLC
21st Mar 20182:17 pmRNSForm 8.3 - Flybe Group PLC
20th Mar 20182:50 pmRNSForm 8.3 - Flybe Group PLC
20th Mar 20182:43 pmRNSForm 8.3 - Flybe Group PLC
19th Mar 201812:38 pmRNSForm 8.3 - Flybe Group PLC
19th Mar 201812:37 pmRNSForm 8.3 - Flybe Group PLC
16th Mar 20181:49 pmRNSForm 8.3 - Flybe Group PLC
16th Mar 20181:44 pmRNSForm 8.3 - Flybe Group PLC
15th Mar 201812:16 pmRNSForm 8.3 - Flybe Group PLC
15th Mar 201812:11 pmRNSForm 8.3 - Flybe Group PLC
12th Mar 20183:13 pmRNSForm 8.3 - Flybe Group PLC
12th Mar 20182:58 pmRNSForm 8.3 - Flybe Group PLC
9th Mar 201811:49 amRNSForm 8.3 - Flybe Group PLC
8th Mar 20183:08 pmRNSForm 8.3 - Flybe Group PLC
8th Mar 201810:26 amRNSForm 8.5 (EPT/RI) - Flybe Group PLC - REPLACEMENT
8th Mar 20189:49 amRNSOpening Position Disclosure - Flybe Group PLC
8th Mar 20189:00 amRNSTrading Update
7th Mar 20187:00 amRNSTransaction in Own Shares
6th Mar 20189:54 amRNSForm 8.3 - Flybe Group PLC
5th Mar 20181:13 pmRNSForm 8.3 - Flybe Group PLC
5th Mar 201812:00 pmRNSForm 8.5 (EPT/RI) - Flybe Group PLC
5th Mar 20187:00 amRNSTransaction in Own Shares
2nd Mar 20187:00 amRNSTransaction in Own Shares
28th Feb 20187:00 amRNSTotal Voting Rights
26th Feb 20182:27 pmRNSForm 8.3 - Flybe Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.